nafisneehal commited on
Commit
3b1a934
·
verified ·
1 Parent(s): 39c823d

Update app.py

Browse files
Files changed (1) hide show
  1. app.py +62 -4
app.py CHANGED
@@ -10,6 +10,57 @@ model = AutoModelForCausalLM.from_pretrained(model_name, torch_dtype=torch.float
10
  model.to(device)
11
  tokenizer = AutoTokenizer.from_pretrained(model_name)
12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
  @spaces.GPU
14
  def generate_response(system_instruction, user_input):
15
  # Format the prompt using the messages structure
@@ -35,18 +86,25 @@ with gr.Blocks() as demo:
35
  # Left sidebar for inputs
36
  with gr.Column():
37
  system_instruction = gr.Textbox(
38
- placeholder="Enter system instruction here...", label="System Instruction")
 
 
 
39
  user_input = gr.Textbox(
40
- placeholder="Type your message here...", label="Your Message")
 
 
 
41
  submit_btn = gr.Button("Submit")
42
 
43
  # Right column for displaying bot response
44
  with gr.Column():
45
  response_display = gr.Textbox(
46
- label="Bot Response", interactive=False, placeholder="Response will appear here.")
 
47
 
48
  # Link submit button to the generate_response function
49
  submit_btn.click(generate_response, [system_instruction, user_input], response_display)
50
 
51
  # Launch the app
52
- demo.launch(share=True)
 
10
  model.to(device)
11
  tokenizer = AutoTokenizer.from_pretrained(model_name)
12
 
13
+ # Default values for system and user input
14
+ test_instruction_string = """
15
+ You're a clinical trial expert. For each trial query, list probable baseline features (each in backticks and comma-separated).
16
+ Baseline features are demographic characteristics used in primary outcome analysis, often shown by group in clinical publications.
17
+ """
18
+
19
+ test_input_string = """
20
+ <Title:>Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction <BriefSummary:>RATIONALE: Drugs used in chemotherapy, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
21
+
22
+ PURPOSE: This pilot trial is studying the side effects and best dose of vinorelbine in treating patients with advanced solid tumors that have not responded to treatment and liver dysfunction. <EligibilityCriteria:>DISEASE CHARACTERISTICS:
23
+
24
+ * Histologically confirmed advanced solid tumor
25
+
26
+ * Any histology allowed
27
+ * Refractory to standard therapy OR no standard therapy exists
28
+
29
+ * Previously untreated non-small cell lung cancer allowed, provided abnormal liver function is present, defined as moderate (group 3) or severe (group 4)
30
+ * Measurable disease not required
31
+
32
+ * Present measurable disease requires baseline measurements within 4 weeks of study entry
33
+ * Patients with acute hepatitis from viral or drug etiologies should recover to a stable baseline prior to study therapy
34
+ * History of brain metastasis allowed, provided the following criteria are met:
35
+
36
+ * Metastasis has been controlled by radiotherapy or surgery
37
+ * Patient is not currently on corticosteroids
38
+ * Neurologic status is stable
39
+
40
+ PATIENT CHARACTERISTICS:
41
+
42
+ * Karnofsky performance status 70-100%
43
+ * Life expectancy ≥ 2 months
44
+ * ANC = 1,500/mm³
45
+ * Platelet count = 100,000/mm³
46
+ * Hemoglobin = 10 g/dL (transfusion to this level allowed)
47
+ * Creatinine \< 1.5 mg/dL OR creatinine clearance \> 60 mL/ min
48
+ * Patients with EKG evidence of first- or second-degree AV block or left or right bundle branch block are ineligible for the lidocaine bolus, but may otherwise be treated on this protocol
49
+ * Not pregnant or nursing
50
+ * Negative pregnancy test
51
+ * Fertile patients must use effective contraception
52
+ * No concurrent illness (e.g., cardiovascular, pulmonary, or central nervous system) that is poorly controlled or of such severity that the investigator deems unwise to enter the patient on protocol
53
+ * Must have ability to comply with study treatment and required tests
54
+ * Obstructive jaundice requires a drainage procedure prior to study treatment
55
+
56
+ PRIOR CONCURRENT THERAPY:
57
+
58
+ * See Disease Characteristics
59
+ * Recovered from prior therapy
60
+ * At least 3 weeks since prior chemotherapy (6 weeks for mitomycin or nitrosourea therapy)
61
+ * No prior radiotherapy to \> 30% of the bone marrow or more than standard adjuvant pelvic radiotherapy for rectal cancer <Conditions:>Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific, <Interventions:>indocyanine green, lidocaine, vinorelbine ditartrate, high performance liquid chromatography, intracellular fluorescence polarization analysis, liquid chromatography, mass spectrometry, pharmacological study <StudyType:>INTERVENTIONAL <PrimaryOutcomes:>Area Under the Curve, Number of Participants With Grade 3 and 4 Toxicities <OverallStatus:>COMPLETED
62
+ """
63
+
64
  @spaces.GPU
65
  def generate_response(system_instruction, user_input):
66
  # Format the prompt using the messages structure
 
86
  # Left sidebar for inputs
87
  with gr.Column():
88
  system_instruction = gr.Textbox(
89
+ value=test_instruction_string,
90
+ placeholder="Enter system instruction here...",
91
+ label="System Instruction"
92
+ )
93
  user_input = gr.Textbox(
94
+ value=test_input_string,
95
+ placeholder="Type your message here...",
96
+ label="Your Message"
97
+ )
98
  submit_btn = gr.Button("Submit")
99
 
100
  # Right column for displaying bot response
101
  with gr.Column():
102
  response_display = gr.Textbox(
103
+ label="Bot Response", interactive=False, placeholder="Response will appear here."
104
+ )
105
 
106
  # Link submit button to the generate_response function
107
  submit_btn.click(generate_response, [system_instruction, user_input], response_display)
108
 
109
  # Launch the app
110
+ demo.launch()